New blood test for Alzheimer's disease

Yet another blood test for Alzheimer's disease is being developed--this time by a group of Japanese researchers. The technique could, if approved, be used to screen patients who show no signs of neurodegeneration. 

Chemistry Nobel laureate Koichi Tanaka, MD, PhD, and colleagues developed the technique in a collaboration between Shimazu and the National Center for Geriatrics and Gerontology in Aichi, Japan. A study was first published in a Japan Academy journal, according to this Japan Times report.

“The amount of blood necessary for a test is just 0.5 cc. We’d like to make it one of the options attached to regular health checks in the future,” said Tanaka. 

Researchers used PET to study the efficacy of the blood test in 62 male and female subjects somewhere between 65 and 85 years of age. The test is being used to detect trace amounts of proteins associated with beta-amyloid deposition and other factors of Alzheimer's disease. 

 

Around the web

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

Trimed Popup
Trimed Popup